Post-transplant recurrent hepatitis C: Immunohistochemical detection of hepatitis C virus core antigen and possible pathogenic implications

Liver International

Volumn 28, Issue 6, 2008, Pages 807-813

  Pessôa, Mário G ^a   Alves, Venancio A F ^a,b   Wakamatsu, Alda ^b   Gomes, Joaquim G ^c   Maertens, Geert ^d   van der Borght, Bart ^d   Kim, Michael ^e   Ferrell, Linda ^e   Wright, Teresa L ^e  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

^c ROCHESTER INSTITUTE OF TECHNOLOGY   (United States)

^d INNOGENETICS   (Belgium)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HCV immunostaining; Post transplant hepatitis C; Post transplantation; Recurrent hepatitis C

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HEPATITIS C ANTIGEN; PREDNISONE; VIRUS RNA;

ANTIGEN DETECTION; ARTICLE; BLOOD LEVEL; CHOLESTATIC HEPATITIS; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE SEVERITY; EARLY DIAGNOSIS; EXPLANT; GRAFT REJECTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; NONHUMAN; PATHOGENESIS; POSTOPERATIVE PERIOD; PROGNOSIS; RECURRENT DISEASE; RNA ANALYSIS; STAINING;

CHOLESTASIS, INTRAHEPATIC; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIGENS; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER; LIVER FAILURE; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RNA, VIRAL; VIRAL CORE PROTEINS;

EID: 44949254926     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01739.x     Document Type: Article

References (28)

1. Rakela J, Vargas HE. Hepatitis C: Magnitude of the problem. Liver Transpl 2002; 8(Suppl. 1): S3-6.
2. Berenguer M. Natural history of recurrent hepatitis C. Liver Transpl 2002; 8(Suppl. 1): S14-8.
3. Testa G, Crippin JS, Netto GJ, et al. Liver transplantation for hepatitis C: Recurrence and disease progression in 300 patients. Liver Transpl 2000; 6: 553-61.
4. Berenguer M, Ferrell L, Watson J, et al. HCV-related fibrosis progression following liver transplantation: Increase in recent years. J Hepatol 2000; 32: 673-84.
5. Feray C, Caccamo L, Alexander GJ, et al. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology 1999; 117: 619-25.
6. Charlton M, Seaberg E, Wiesner R, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998; 28: 823-30.
7. Gane EJ, Portmann BC, Naoumov N, et al. Long-term outcome of hepatitis C infection after liver transplantation. New Engl J Med 1996; 334: 815-20.
8. Taga SA, Washington MK, Terrault N, et al. Cholestatic hepatitis C in liver allografts. Liver Transpl Surg 1998; 4: 304-10.
9. Schluger LK, Sheiner PA, Thung SN, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996; 23: 971-6.
10. Dickson RC, Caldwell SH, Ishitani MB, et al. Clinical and histologic patterns of early graft failure due to recurrent hepatitis C in four patients after liver transplantation. Transplantation 1996; 61: 701-5.
11. Doughty AL, Spencer JD, Cossart YE, McCaughan GW. Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels. Liver Transpl Surg 1998; 4: 15-21.
12. Pessoa MG, Bzowej N, Berenguer M, et al. Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation. Hepatology 1999; 30: 1513-20.
13. Rosen HR, Hinrichs DJ, Gretch DR, et al. Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation. Gastroenterology 1999; 117: 926-32.
14. Ballardini G, De Raffele E, Groff P, et al. Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus-reinfected liver. Liver Transpl 2002; 8: 10-20.
15. Guerrero RB, Batts KP, Burgart LJ, et al. Early detection of hepatitis C allograft reinfection after orthotopic liver transplantation: A molecular and histologic study. Mod Pathol 2000; 13: 229-37.
16. Gane EJ, Naoumov NV, Qian KP, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996; 110: 167-77.
17. Doughty AL, Painter DM, McCaughan GW. Nonspecificity of monoclonal antibody Tordji-22 for the detection of hepatitis C virus in liver transplant recipients with cholestatic hepatitis. Liver Transpl Surg 1999; 5: 40-5.
18. Alves V, Wakamatsu A, Nonogaki S, et al. Hepatitis C -immunohistochemical detection of HCV core antigen and possible pathogenic implications. Mod Pathol 1998; 2: 150A.
19. Scheuer P. Classification of chronic viral hepatitis: A need for reassessment. J Hepatol 1991; 13: 372-4.
20. Chazouilleres O, Kim M, Combs C, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994; 106: 994-9.
21. Weiner AJ, Brauer MJ, Rosenblatt J, et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 1991; 180: 842-8.
22. Davidson F, Simmonds P, Ferguson J, et al. Survey of major genotypes and subtypes of hepatitis C using RFLP of sequences amplified from the 5′ non-coding region. J Gen Virol 1995; 76: 1197-204.
23. Simmonds P, Alberti A, Alter H, et al. A proposed system for the nomenclature of hepatitis C virus genotypes. Hepatology 1994; 19: 1321-4.
24. Krawczynski K, Beach M, Di Bisceglie A, et al. Hepatocellular HCV-associated antigen and antibody: Viral specificity and relation to natural history of infection. Hepatology 1990; 12: 905.
25. Roskams T. The role of immunohistochemistry in diagnosis. Clin Liver Dis 2002; 6: 571-89.
26. Scheuer PJ, Krawczynski K, Dhillon AP. Histopathology and detection of hepatitis C virus in liver. Springer Semin Immunopathol 1997; 19: 27-45.
27. Deshpande V, Burd E, Aardema KL, et al. High levels of hepatitis C virus RNA in native livers correlate with the development of cholestatic hepatitis in liver allografts and a poor outcome. Liver Transpl 2001; 7: 118-24.
28. Zervos X, Weppler D, Berho M, et al. Increased hepatitis C viremia in cholestatic hepatitis C following orthotopic liver transplantation. Is the pathogenicity of the syndrome related to viral cytopathic mechanisms? Transplantation 1998; 65(Suppl.): 181A.